Oral glucose tolerance test with prolonged determination of glucose, insulin and C-peptide levels in patients with Cystic Fibrosis
Recruiting
- Conditions
- Cystic FibrosisOral glucose tolerance testDiabetes
- Registration Number
- NL-OMON22533
- Lead Sponsor
- Initiator
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 18
Inclusion Criteria
1. Cystic Fibrosis patients
2. Proven diagnosis cystic fibrosis: either positive genotyping or raised sweat sodium
Exclusion Criteria
1. Absent oral glucose tolerance test in last half year
2. Cystic fibrosis-related diabetes diagnosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose levels, blood insulin levels and blood C-peptide levels during OGTT and after OGTT during a follow-up period of 3 hours.
- Secondary Outcome Measures
Name Time Method Insulin resistance and ß-cell function, calculated respectively by HOMA-IR and <br>HOMA-B. <br /><br>Areas under the curve for glucose, insulin and c-peptide levels. <br /><br>Peak glucose levels.<br /><br>